Troponin: The biomarker of choice for the detection of cardiac injury

Luciano Babuin, Allan S. Jaffe

Research output: Contribution to journalReview articlepeer-review

425 Scopus citations


It has been known for 50 years that transaminase activity increases in patients with acute myocardial infarction. With the development of creatine kinase (CK), biomarkers of cardiac injury began to take a major role in the diagnosis and management of patients with acute cardiovascular disease. In 2000 the European Society of Cardiology and the American College of Cardiology recognized the pivotal role of biomarkers and made elevations in their levels the "cornerstone" of diagnosis of acute myocardial infarction. At that time, they also acknowledged that cardiac troponin I and T had supplanted CK-MB as the analytes of choice for diagnosis. In this review, we discuss the science underlying the use of troponin biomarkers, how to interpret troponin values properly and how to apply these measurements to patients who present with possible cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)1191-1202
Number of pages12
Issue number10
StatePublished - Nov 8 2005

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Troponin: The biomarker of choice for the detection of cardiac injury'. Together they form a unique fingerprint.

Cite this